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Cardiovascular magnetic resonance imaging (CMRI) which combines high 
image quality with advanced techniques to probe cardiovascular system is devel-
oping rapidly. Also, as a noninvasive imaging equipment, it has been accepted 
widely in clinical application. CMRI techniques produce high spatial, contrast, and 
temporal resolution image data for evaluation of cardiac and great vessel anatomy, 
coronary artery imaging, regional tissue characterization, vascular blood flow, 
cardiac chamber filling and contraction, and myocardial perfusion, myocardial 
viability. This chapter will cover the basic techniques of CMRI, practical tricks 
of how to perform CMRI, and clinical application in a variety of congenital heart 
disease, coronary artery disease, and non-ischemic heart disease, etc.
Keywords: cardiovascular magnetic resonance, morphology, ventricular function, 
myocardial perfusion, late gadolinium enhancement, coronary artery disease
1. Introduction
CMRI is complementary to other imaging techniques, such as echocardiography, 
cardiac CT, and nuclear medicine. The technique has a key role in evidence-based 
diagnostic and therapeutic pathways in cardiovascular disease. In the past 10 years, 
the development of CMRI is an active field of research and continues to see a rapid 
expansion of new and emerging techniques. CMRI applications include assessment 
of myocardial ischemia and viability, cardiomyopathies, myocarditis, vascular 
diseases, and congenital heart disease [1].
2. Technical consideration for CMRI
CMRI uses the same basic principles of image acquisition and reconstruction as 
other MRI techniques. Imaging of the cardiovascular system is usually performed 
with cardiac gating using an adaptation of electrocardiograph gating (ECG). ECG 
signal is used to either prospectively trigger data acquisition or retrospectively gate 
data reconstruction. Respiratory gating techniques have also been utilized to com-
pensate respiratory motion. This can be implemented with either acquisition during 
a consistent part of the respiratory phase (typically the end-expiratory phase) or 
post-processing of continuously acquired data [2].
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2.1 Evaluation of cardiac morphology
Dark-blood fast spin echo is usually applied for the observation of cardiac 
anatomy. Another advantage of cardiac MRI is that blood can also become bright 
when using gradient echo sequence, such as SSFP. By using one RF pulse to generate 
the signal, gradient echo sequence avoids the washout effect and the signal from 
flowing blood appears apparently bright. Contrast between the blood and the 
myocardium can be generated without contrast agent [3].
The evaluation of cardiac morphology usually starts from three basic planes: 
axial, coronal, and sagittal planes like standard views of the thorax. Figure 1 
illustrates the standard cardiac imaging views.
2.2 Assessment of ventricular function
The standard approach to measure LV volume and function includes steady-state 
free precession (SSFP) gradient echo sequence, with one slice acquired during a 
breath hold of about 10–15 heartbeats [4]. It acquires in two-chamber view, four-
chamber view, short-axis view, and left ventricle/right ventricular inlet-outlet view 
which also allow evaluation of the valvular insufficiency, outflow tract obstruction, 
mobility of the cardiac tumors. CMRI is the reference standard for the assessment 
of cardiac structure and function and is valuable for diagnosis and surgical plan-
ning in congenital heart disease. Since the sequence are vulnerable to magnetic 
susceptibility artifact at 3.0 T, spoiled gradient recalled echo can be used as a 
substitute. By tracing the endocardial and epicardial borders at end-diastole and 
Figure 1. 
Basic CMRI views. A. Localizer scans showed three standard coronal, sagittal, and transverse planes. 
B. Planning of the vertical long axis (VLA) image from the trans-axial image (orange line). C. Planning of 
the helical long axis (HLA) from VLA (blue line). Short axis (SA) images from VLA and HLA images (green 
line). D. Planning of 4-chamber (4-ch) image from VLA and SA images (purple line). E. Planning of 2-ch 
image form 4-ch image and SA image (pink line). F. SA image was obtained from 4-ch and 2-ch image (yellow 
line). G. Left ventricular out flow (LVOT) view from SA image and 2-ch image (brown line), and LVOT 
coronal view from the original LVOT image (white line).
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end-systole from short-axis images occupying the heart from base to apex through-
out the cardiac cycle, the parameters such as LV and RV mass, volumes, wall 
thickness, wall motion and ejection fraction are obtained and quantified through 
multiple breath hold [5].
A useful variant of cine imaging for use with motion evaluation is to combine it 
with magnetization tagging. These tag lines provide 3D analysis of cardiac rota-
tion, strain, displacement, and deformation of different myocardial layers during a 
cardiac cycle.
2.3 Myocardial perfusion
The fundamental principle of first-pass perfusion imaging is relatively simple. 
Multiple imaging planes through the heart are taken every heartbeat. These images 
are used to track an intravenous bolus of contrast dynamically as it courses through 
the cardiac chambers and into the myocardium. Because the gadolinium primarily 
shortens T1 relaxation, the heart appears dark until contrast is delivered via blood 
flow or perfusion.
First-pass perfusion is divided into rest and stress perfusion. Rest perfusion 
detects myocardial perfusion deficits through first-pass kinetics of a contrast 
agent bolus, thus, it also named dynamic first-pass perfusion imaging. Ultrafast 
sequences like inversion recovery prepared fast gradient echo, interleaved 
gradient-echo echo-planar imaging, and saturation recovery SSFP sequence can 
assess signal intensity changes. Since myocardium has a relatively strong reserve 
capacity, perfusion deficits at rest is insensitive to myocardial ischemia. Induced 
by pharmaceutical agents, such as adenosine and dipyridamole, stress perfusion 
provokes coronary vasodilation and increases the contractile function compensated 
by increasing myocardial perfusion. Normal arteries can be dilated and respond to 
stress, whereas severely narrowed arteries limit flow, thus resulting deficits of the 
perfusion which may cause the wall motion abnormalities. Hence, an asymptomatic 
CAD can be identified by perfusion imaging through depicting perfusion defects 
under stress. There are different levels for the analysis of myocardial perfusion, 
which are qualitative, semi-quantitative, and fully quantitative evaluation. Since the 
dynamically acquired images include the whole information of first-pass perfusion, 
most clinicians used qualitative visual interpretation of clinical studies [6, 7].
2.4 Late gadolinium enhancement
Late gadolinium enhancement (LGE) image has been extensively validated in 
clinical studies and capable for detecting myocardial viability. By using segmented 
(or single shot) inversion-recovery prepared fast (or turbo) gradient sequence, 
combined with intravenous infusion of gadolinium-based contrast agent, LGE 
image can be obtained. By applying appropriate inverted time, the normal myocar-
dial signal is null, and the difference between infarcted and normal myocardium is 
optimized. Myocyte degradation and membrane permeability increased contrast 
accumulation in acute myocardial infarction. Chronic myocardial infarction is 
characterized by fibrous tissue with larger interstitial space in which contrast agent 
accumulates [8].
2.5 Myocardial T1 and T2 mapping
Paramagnetic mapping techniques such as T1 mapping and T2 mapping offer 
a robust and reproducible quantitative assessment of both focal or diffuse fibro-
sis, edema and amyloidosis. T1 Mapping is performed with inversion recovery 
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(Look-Locker, MOLLI, ShMOLLI) or saturation recovery pulse technology (SASHA, 
SAPPHIRE) within a single breath hold. Myocardial T2 mapping is a technique used 
to reconstruct a parametric image based on the T2 value measured in each voxel. The 
accumulation of water in the myocardium is associated with different types of pathol-
ogy, such as acute myocardial infarction, myocarditis and graft rejection [9–11].
2.6 Vascular imaging
CMRI can assess large and medium-sized vascular structures and are particu-
larly useful in the pediatric population with congenital abnormalities of the aorta. 
Vascular imaging techniques includes non-contrast enhanced magnetic resonance 
angiography (NCE-MRA) and contrast enhanced-magnetic resonance angiography 
(CE-MRA).
2.6.1 NCE-MRA
Time of flight MRA (TOF-MRA) is a widely used technique for vascular imag-
ing. By using a flow-related enhancement, it gives rise to bright blood contrast with 
very short TR spoiled gradient echo pulse sequences. Through one rapid RF pulse, 
the tissue of whose magnetization remains in the image slice, has become partially 
saturated. Thus, the flowing blood that moves into the slice has not received any 
previous pulses and appears bright or enhanced and tissues surrounding it appears 
dark. TOF-MRA has been used in noninvasive angiography of the intracranial 
angiography and carotid angiography.
More recently, 4D flow MRI referring to three-dimensional data acquired in 
a time-resolved, ECG-gated, manner with velocity encoding in all three spatial 
directions has appeared. In addition to the measurements of basic flow volumes 
and velocities, the estimation of derived hemodynamic biomarkers such as wall 
shear forces, pulse-wave velocity, pressure gradients, and other measures have been 
proposed. 4D flow imaging can be used in the clinical evaluation and management 
of patients with aortic disease. As an emerging tool for the comprehensive evalu-
ation of cardiovascular hemodynamics with full volumetric coverage, 4D flow is a 
continuously developing field of research [12].
2.6.2 CE-MRA
Bolus injection of MRI contrast agent can increase the signal of the heart 
instantly, which can be used to generate image contrast between vessel and sur-
rounding tissues. Imaging is usually performed on 3D-T1 weighted spoiled gradient-
echo pulse sequence with short TR and TE. Blood was consistently hyper-intensity 
and background tissue was hypo-intensity on the contrary due to saturation effects, 
thus, a better MRA images is obtained, and by subtracting plain images before, a 
high quality MRA images are obtained.
Taking thoracic aorta CE-MRA for example. A 3D-T1 weighted spoiled gradient-
echo pulse sequence is performed to acquire non-enhanced images (mask image); 
then, small dose of contrast agent (2 ml) is injected to test the time course of indi-
vidual contrast kinetics. Imaging delay time can be calculated as estimated contrast 
travel time + Injection time/2 – Imaging time/2.
By injecting gadolinium-based agent intravenously (0.2 mmol/kg, 3 ml/s), 
another 3D-T1 weighted spoiled gradient-echo pulse sequence (same parameter as 
pre-contrast) was used. Image quality can be further improved by image subtrac-
tion, where a non-contrast (“mask”) images is subtracted from each post-contrast 
images.
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2.7 Coronary MRA
Whole heart CMRA, as a method of providing visualization of all three major 
coronary arteries in a single 3D volume, has been successfully introduced at 1.5 T 
MRI. Recently, some single and multicenter studies suggest that 1.5 T whole heart 
CMRA can eliminate the need for diagnostic coronary catheterization in many 
patients who are at risk of CAD. 3.0 T cardiovascular MR has become active for the 
evaluation of CAD in recent years (Figure 2). Contrast-enhanced coronary MRA 
at 3.0 T improves SNR and contrast-to-noise ratio and shows high accuracy in 
the detection of significant coronary artery stenosis. Both MDCT and CMRA can 
lumenographic information about the coronary arteries in the determination of 
existence and extent of CAD. Even though, the accuracy is be inferior to coronary 
CT angiography and spatial resolution needs a further improved, CMRA has the 
potential to be a valuable adjunct in cases where coronary calcification precludes 
adequate evaluation or iodinated contrast agents are contraindicated [13].
3. Clinical application of CMRI
3.1 Assessment of congenital heart disease
CMRI has been shown to provide helpful diagnostic information in most types 
of congenital heart disease. The clinical indications for a CMRI examination involve 
one or more of the following situations:
1. When trans-thoracic echocardiography is incapable of providing the required 
diagnostic information.
2. As an alternative to cardiac CT with its associated radiation in pediatric patients.
3. To obtain diagnostic information for which CMR offers unique advantages.
Detailed pre-examination planning is crucial due to the complex nature of the 
clinical, anatomical, and functional issues in patients with congenital heart disease. 
Careful review of the patient’s medical history are always needed. For example, in 
patients with ventricular septal defect (VSD), measurement of ventricular dimen-
sions and function is a key element of the CMRI evaluation. This can be done from 
the ventricular short- axis cine MRI image stack. Larger left-to-right shunts will 
result in left ventricular dilation but not right ventricular dilation. Quantification of 
the VSD shunt can be performed by calculating the Q p/Qs ratio. This can be accom-
plished by measuring the net blood flow in the main pulmonary artery (Q p) and 
the ascending aorta (Qs) using VEC MRI. VEC MRI measurements have been used 
Figure 2. 
3D free-breathing contrast enhancement coronary angiography at 3.0 Tesla MRI.
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to gain insight into the functional significance of an obstruction. Flow character-
istics suggests a hemodynamically significant coarctation through decreased peak 
flow, decreased time-averaged flow, decreased acceleration rate, and prolonged 
deceleration with increased antegrade diastolic flow, delayed onset of descending 
aorta flow compared with the onset of flow in the ascending aorta [14, 15].
3.2 Assessment of CAD
CMR can provide data in all of these aspects of coronary heart disease (CAD), 
including cardiac morphology, global and regional myocardial function, myocar-
dial ischemia, viability of myocardium, and the presence of coronary stenosis. 
Comprehensive CMRI protocols have been mainly applied to two clinical scenarios: 
the detection of CAD and the assessment of viability.
CMRI can accurately assess cardiac morphology, global and regional cardiac 
function as well as deformed ventricles. Cine imaging forms an essential component 
of any CMRI study in CAD. Myocardial ischemia as the principal manifestation of 
CAD can be detected by first-pass perfusion test. Rest myocardial blood flow will 
keep constant unless the significant stenosis exists, thus, physiological or pharma-
cological stress is necessary for the detection of myocardial ischemia. LGE images 
of myocardial scar using current segmented inversion recovery gradient echo pulse 
sequences can be obtained in one breath hold.
Gadolinium-based contrast agents are extra-cellular, thus, they can diffuse 
freely in to the interstitial space. In acute myocardial infarction, the cell barriers 
were destroyed, and distribution volume is increased. In chronic infarction myo-
cardial cells are replaced with a fibrotic matrix which also cause the distribution 
volume increasing. LGE always extends from the endocardium outwards due to 
the process of myocyte necrosis spreading from sub-endocardium to the epicardial 
borders. Figure 3 is an inversion recovery delayed-enhancement image acquisition 
program with phase-sensitive detection was used to acquire LGE images from an 
inferior non-transmural myocardial infarcted patient (yellow arrow). LGE can not 
only determine the presence, location and extent of infarcted myocardium, but also 
can identify the stunned myocardium prior to revascularization [7].
3.3 Assessment of non-ischemic heart disease
Non-Ischemic heart disease includes hypertrophic cardiomyopathy (HCM), dilated 
cardiomyopathy (DCM), restrictive cardiomyopathy (RCM), myocarditis, et al.
Figure 3. 
An inversion recovery delayed-enhancement image acquisition program with phase-sensitive detection was used 
to acquire LGE images from an inferior wall non-transmural myocardial infarcted patient (yellow arrow). 
The inversion time (a timing option) was adjusted to null the normal myocardium. Thus, normal myocardium 
appears uniformly dark in these ventricular sagittal (a) and short axis (b and c) views.
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Most of the non-ischemic heart disease is characterized by an alteration of ven-
tricular and myocardial geometry or function. For the measurement of morphology 
and function, a stack of short-axis slices covering the entire left ventricle from the 
mitral plane to the apex can be used [16].
LGE further enhances the tissue characterization abilities of CMRI which 
shortens T1 relaxation time and brightens the area where gadolinium chelates 
accumulates. Myocardial tissue characterization of non-ischemic heart disease can 
be quantitatively evaluated through T1 mapping and T2 mapping.
3.3.1 Hypertrophic cardiomyopathy (HCM)
HCM is a genetic disease characterized by myocardial disarray, symmetrical or 
asymmetrical myocardial hypertrophy, most frequently occur in the septum with 
the loss of diastolic function or (and) possible dynamic systolic obstruction of the 
LV outflow tract [17]. Cine imaging can accurately assess the wall thickness, and it 
can be used to detect anterior motion of mitral valve leaflet in systole. Myocardial 
tagging imaging shows a decreasing of circumferential shortening and fractional 
thickening in region of thickened myocardium. LGE imaging can determine 
the areas of fibrosis based on increasing collagen content, which have a positive 
correlation with risk of lethal arrhythmias [18]. Figure 4 is typical images of HCM 
diagnosed by CMR.
3.3.2 Dilated cardiomyopathy (DCM)
DCM is characterized by progressive LV enlargement and deteriorated LV func-
tion with normal LV wall thickness. A diffuse myocardial fibrosis is usually detected 
in histopathological studies. LGE can accurately demonstrate the enhancement of 
ischemic DCM begins from sub-endocardial layers, while, focal fibrosis in non-
ischemic DCM spares the sub-endocardial layers and shows either mid-wall patchy 
enhancement pattern or lack of enhancement. CMR Cine reveals an increasing LV 
mass, LV volume and ejection fraction as well as hypo-kinetic wall motion. Focal 
septal fibrosis in DCM, the so-called mid-wall sign, has been linked to ventricular 
arrhythmia which is a main cause of sudden death.
3.3.3 Restrictive cardiomyopathy (RCM)
Primary RCM is characterized by impaired diastolic volume of both ventricles 
without dysfunction of systolic, a biatrial dilation and normal or small LV size 
can also be detected. CMR can assess RCM accurately based on its high contrast 
Figure 4. 
Hypertrophic cardiomyopathy. A. Black blood image showed symmetric myocardial hypertrophy (yellow 
asterisks). B. Left ventricular outflow tract obstruction and a turbulent flow within the aorta (white arrow, B). 
C. LGE image demonstrated heterogeneous enhancement of the hypertrophied myocardium (yellow arrowheads).
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resolution and the ability of comprehensive evaluation of cardiomyopathies. Phase 
contrast imaging allows quantitative assessment of flow across the atrioventricular 
valves. In early stage, reduced diastolic function causes the decrease of early ven-
tricular relaxation velocities and the increase of late atrial contraction velocities. In 
later period, a restrictive filling will appear with rapid and tall early filling waves 
and much reduced atrial waves. In RCM patients, contours of ventricular cavities are 
maintained with atrial enlargement. Myocardial thickness is frequently increased 
in RCM.
3.3.4 Myocarditis
Endocardium biopsy is “golden standard” but invasive diagnosis for myocarditis. 
CMR is the best imaging technique to confirm suspected myocarditis and detect 
focal inflammation and scarring. The diagnostic criteria of CMR for myocarditis 
was proposed for the first time in the year of 2006 [19], which depicted that myo-
carditis would have the following characteristics: 1. hyper-enhancement on LGE 
images, not confined to specific coronary territory, but in typically sub-epicardiac 
or intramural (Figure 5); 2. The hyper-enhancement lesions is less bright than myo-
cardial infarction and most frequently arise in the inferolateral wall. Furthermore, 
T2-weighted CMR T1 mapping can detect the edema which appears local or diffus-
ing hyper-enhancement.
4. Conclusion
CMRI has revolutionized cardiac imaging. CMRI gives complementary infor-
mation on LV function, perfusion, and myocardial viability. Recent advances in 
cardiac imaging include T1 mapping, T2 mapping, and MR-guided therapy. With 
the promise of higher spatial–temporal resolution and 3D coverage at higher field 
strength, in the near future, CMRI will become an routine tool in the diagnosis of 
cardiac diseases.
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Figure 5. 
A T2 Stir image from a myocarditis patient. High T2 signal indicating edema is seen in subepicardial area 
of septum, lateral wall, etc. (yellow arrowheads). LGE shows enhancements occur in the same area (blue 
arrowheads).
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